InvestorsHub Logo
Followers 36
Posts 1736
Boards Moderated 0
Alias Born 05/13/2011

Re: None

Sunday, 03/24/2019 4:45:54 PM

Sunday, March 24, 2019 4:45:54 PM

Post# of 169
'Yet there is an "over-focus" on Bristol-Myers Squibb's decision to shed the three projects, CytomX Chairman, President and CEO Sean McCarthy told the San Francisco Business Times. The collaboration still consists of nine other targets, he said, including the ongoing Phase I/II study that will produce preliminary data this year.'

https://www.bizjournals.com/sanfrancisco/news/2019/02/26/bristol-myers-squibb-bms-cytomx-ctmx-cancer.html
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CTMX News